Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Chroma Therapeutics (WO 2005/019826 )

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of chemically modified chromosome fragments. The company's assets is involved in the development, made by scientists working at Chroma Therapeutics Limited and in the detection of chemically modified chromosome fragments, called nucleosomes, from cancer cells circulating in the blood of cancer patients.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Primary Office
  • 93 Innovation Drive
  • Milton Park
  • Abingdon OX14 4RY
  • England, United Kingdom

+44 01235 000000

Chroma Therapeutics (WO 2005/019826 ) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Chroma Therapeutics (WO 2005/019826 )‘s full profile, request access.

Request full access to PitchBook

Chroma Therapeutics (WO 2005/019826 ) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Chroma Therapeutics (WO 2005/019826 )‘s full profile, request access.

Request full access to PitchBook